Literature DB >> 33323453

Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis.

Yali Fan1, Chunming Zheng2, Na Wu1, Yihua Li1, Xiaoyun Huang1, Qiao Ye3.   

Abstract

OBJECTIVES: Telomerase gene variants that lead to accelerated telomere shortening are linked to progressive-fibrosing interstitial lung diseases. However, little is known about their relationships with pneumoconiosis. This study aimed to identify TERT/TERC variants and leucocyte telomere lengths (LTL) in patients with silicosis or asbestosis.
METHODS: In the present study, Sanger sequencing of TERT/TERC variants was performed in 193 Chinese Han patients with pneumoconiosis, including 109 with silicosis and 84 with asbestosis. Quantitative PCR was used to measure LTL in peripheral blood of the patients and 200 age and sex-matched healthy controls.
RESULTS: In total, 7.3% patients with pneumoconiosis had 17 TERT/TERC variants. Among which 8.3% of patients with silicosis and 3.6% of patients with asbestosis had TERT variants, respectively. No TERC variants were detected in silicosis, whereas 3.6% of patients with asbestosis had TERC variants. Telomeres were significantly shorter in the patients with pneumoconiosis compared with healthy controls (p<0.001). No significant differences in LTL were found between TERT/TERC variant carriers and non-carriers. Exposure to silica dust was associated with the severity of pneumoconiosis after adjusting for covariates (OR 4.92, p=0.002). However, TERT/TERC variants and short telomeres were not associated with the severity of pneumoconiosis.
CONCLUSION: Telomerase gene variants and short telomeres may be identified in the patients with silicosis and asbestosis in response to the exposure to silica or asbestos dust but are not related to disease severity. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  asbestos; clinical medicine; dust; mutation; occupational health

Year:  2020        PMID: 33323453     DOI: 10.1136/oemed-2020-107046

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  2 in total

1.  Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study.

Authors:  Jelle R Miedema; Catharina C Moor; Marcel Veltkamp; Sara Baart; Natascha S L Lie; Jan C Grutters; Marlies S Wijsenbeek; Rémy L M Mostard
Journal:  Respir Res       Date:  2022-05-28

2.  OC-STAMP Overexpression Drives Lung Alveolar Epithelial Cell Type II Senescence in Silicosis.

Authors:  Tian Li; Xin-Yu Yang; Ding-Jie Xu; Zi-Yi Gao; Yi-Bing Gao; Fu-Yu Jin; Ya-Qian Li; Shu-Peng Liu; Shi-Feng Li; Xue-Min Gao; Wen-Chen Cai; Na Mao; Zhong-Qiu Wei; He-Liang Liu; Ying Sun; Fang Yang; Hong Xu
Journal:  Oxid Med Cell Longev       Date:  2021-08-14       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.